CS
ASPX

Credit Suisse’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Credit Suisse’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-25,543
Closed -$2.56M – 4770
2015
Q1 		$2.56M Sell
25,543
-5,883
-19% -$392K ﹤0.01% 2188
2014
Q4 		$1.65M Buy
31,426
+22,215
+241% +$652K ﹤0.01% 2711
2014
Q3 		$237K Buy
+9,211
New +$196K ﹤0.01% 4054

Credit Suisse's ASPX Position: Q2 2015 in Review

Credit Suisse sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 25,543 shares — an estimated $2.56M sold.

Credit Suisse first reported a position in ASPX in Q3 2014 and held it in 3 quarters. The position peaked at $2.56M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Credit Suisse reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Credit Suisse sold 25,543 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $2.56M.
  • Credit Suisse first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q3 2014 and held it in 3 quarters.
  • Credit Suisse's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $2.56M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Credit Suisse's 13F filing for Q2 2015, filed 13 Aug 2015.